特应性皮炎的诊断：争议和事实

doi:10.35541/cjd.20190737

中华皮肤科杂志 ›› 2021, Vol. 54 ›› Issue (1): 89-92.doi: 10.35541/cjd.20190737

• 综述 • 上一篇

特应性皮炎的诊断：争议和事实

宋潇,宋志强

陆军军医大学西南医院皮肤科，重庆 400038

收稿日期:2019-07-10 修回日期:2020-01-23 发布日期:2021-01-05
通讯作者: 宋志强 E-mail:zhiqiang.song@hotmail.com
基金资助:
国家自然科学基金（81673059）；陆军军医大学西南医院创新团队建设培养计划项目（SWH2018TD-02）

Diagnosis of atopic dermatitis: controversies and facts

^{Song Xiao, Song Zhiqiang}

Department of Dermatology, Southwest Hospital, Army Medical University, Chongqing 400038, China

Received:2019-07-10 Revised:2020-01-23 Published:2021-01-05
Contact: Song Zhiqiang E-mail:zhiqiang.song@hotmail.com
Supported by:
National Natural Science Foundation of China（81673059）; Army Medical University Southwest Hospital Innovative Team Construction Training Project （SWH2018TD-02）

摘要/Abstract

摘要： 【摘要】特应性皮炎是一种常见的与遗传过敏性体质相关的以湿疹样皮疹和瘙痒为主要特征的慢性复发性炎症性疾病。其病因及发病机制尚不十分清楚，导致其起源、定义、临床表型及诊断标准等存在较多争议，本文就上述争议进行分析及探讨，以期为特应性皮炎的诊治提供有意义的参考。

关键词: 皮炎, 特应性, 诊断, 定义, 争议

Abstract: 【Abstract】 Atopic dermatitis is a common chronic recurrent atopic constitution-associated inflammatory skin disease mainly characterized by eczematous lesions and itching. Its etiology and pathogenesis are still not very clear, thus, there are many controversies about its origin, definition, clinical phenotypes and diagnostic criteria. This review analyzes and discusses these controversies in order to provide a meaningful reference for the diagnosis and treatment of atopic dermatitis.

Key words: Dermatitis, atopic, Diagnosis, Definition, Controversy

宋潇宋志强. 特应性皮炎的诊断：争议和事实[J]. 中华皮肤科杂志, 2021,54(1):89-92. doi:10.35541/cjd.20190737

Song Xiao, Song Zhiqiang. Diagnosis of atopic dermatitis: controversies and facts[J]. Chinese Journal of Dermatology, 2021, 54(1): 89-92.doi:10.35541/cjd.20190737

参考文献 32

［1］	Kauppi S, Jokelainen J, Timonen M, et al. Adult patients with atopic eczema have a high burden of psychiatric disease: a finnish nationwide registry study［J］. Acta Derm Venereol, 2019,99（7）:647⁃651. doi: 10.2340/00015555⁃3165.
［2］	Wang AR, Dunlap RR, Darwish MA, et al. Initial validation of the burden of disease in atopic eczema instrument, a quality⁃of⁃life measure for adult atopic dermatitis［J］. Br J Dermatol, 2018,178（5）:1211⁃1212. doi: 10.1111/bjd.16398.
［3］	Werfel T, Schwerk N, Hansen G, et al. The diagnosis and graded therapy of atopic dermatitis［J］. Dtsch Arztebl Int, 2014,111（29⁃30）:509⁃520, i. doi: 10.3238/arztebl.2014.0509.
［4］	Bieber T. Why we need a harmonized name for atopic dermatitis/atopic eczema/eczema!［J］. Allergy, 2016,71（10）:1379⁃1380. doi: 10.1111/all.12984.
［5］	Kantor R, Thyssen JP, Paller AS, et al. Atopic dermatitis, atopic eczema, or eczema? A systematic review, meta⁃analysis, and recommendation for uniform use of ′atopic dermatitis′［J］. Allergy, 2016,71（10）:1480⁃1485. doi: 10.1111/all.12982.
［6］	Bieber T. Atopic dermatitis［J］. Ann Dermatol, 2010,22（2）:125⁃137. doi: 10.5021/ad.2010.22.2.125.
［7］	Liu P, Zhao Y, Mu ZL, et al. Clinical features of adult/adolescent atopic dermatitis and chinese criteria for atopic dermatitis［J］. Chin Med J （Engl）, 2016,129（7）:757⁃762. doi: 10.4103/0366⁃6999.178960.
［8］	Xu S, Thyssen JP, Paller AS, et al. Eczema, atopic dermatitis, or atopic eczema: analysis of global search engine trends［J］.Dermatitis, 2017,28（4）:276⁃279. doi: 10.1097/DER.0000000000 000273.
［9］	Yang EJ, Sekhon S, Sanchez IM, et al. Recent developments in atopic dermatitis［J］. Pediatrics, 2018,142（4）:e20181102. doi: 10.1542/peds.2018⁃1102.
［10］	Darsow U, Wollenberg A, Simon D, et al. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis［J］. J Eur Acad Dermatol Venereol, 2010,24（3）:317⁃328. doi: 10.1111/j.1468⁃3083.2009.03415.x.
［11］	Wadonda⁃Kabondo N, Sterne JA, Golding J, et al. Association of parental eczema, hayfever, and asthma with atopic dermatitis in infancy: birth cohort study［J］. Arch Dis Child, 2004,89（10）:917⁃921. doi: 10.1136/adc.2003.034033.
［12］	Manti S, Amorini M, Cuppari C, et al. Filaggrin mutations and Molluscum contagiosum skin infection in patients with atopic dermatitis［J］. Ann Allergy Asthma Immunol, 2017,119（5）:446⁃451. doi: 10.1016/j.anai.2017.07.019.
［13］	Silverberg NB. Typical and atypical clinical appearance of atopic dermatitis［J］. Clin Dermatol, 2017,35（4）:354⁃359. doi: 10.1016/j.clindermatol.2017.03.007.
［14］	Howells L, Thomas KS, Sears AV, et al. Defining and measuring ′eczema control′: an international qualitative study to explore the views of those living with and treating atopic eczema［J］. J Eur Acad Dermatol Venereol, 2019,33（6）:1124⁃1132. doi: 10.1111/jdv.15475.
［15］	Hanifin JM. Atopic dermatitis nomenclature variants can impede harmonization［J］. J Invest Dermatol, 2012,132（2）:472⁃473; author reply 473⁃474. doi: 10.1038/jid.2011.292.
［16］	Andersen RM, Thyssen JP, Maibach HI. Qualitative vs. quantitative atopic dermatitis criteria ⁃ in historical and present perspectives［J］. J Eur Acad Dermatol Venereol, 2016,30（4）:604⁃618. doi: 10.1111/jdv.13442.
［17］	Stoenescu M. "Atopy", "allergy" and "hypersensitivity" are⁃⁃explicitly or implicitly⁃⁃defined in different ways. Allergy, 1999,54（6）:640⁃642.
［18］	Bieber T. How to define atopic dermatitis? ［J］. Dermatol Clin, 2017, 35（3）: 275⁃281. doi: 10.1016/j.det.2017.02.001.
［19］	Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003［J］. J Allergy Clin Immunol, 2004,113（5）:832⁃836. doi: 10.1016/j.jaci.2003.12.591.
［20］	Wollenberg A, Oranje A, Deleuran M, et al. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients［J］. J Eur Acad Dermatol Venereol, 2016,30（5）:729⁃747. doi: 10.1111/jdv.13599.
［21］	Katayama I, Aihara M, Ohya Y, et al. Japanese guidelines for atopic dermatitis 2017［J］. Allergol Int, 2017,66（2）:230⁃247. doi: 10.1016/j.alit.2016.12.003.
［22］	Suárez⁃Fariñas M, Dhingra N, Gittler J, et al .Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis［J］. J Allergy Clin Immunol, 2013,132（2）:361⁃370. doi: 10.1016/j.jaci.2013.04.046.
［23］	Roguedas⁃Contios AM, Misery L. What is intrinsic atopic dermatitis?［J］. Clin Rev Allergy Immunol, 2011,41（3）:233⁃236. doi: 10.1007/s12016⁃011⁃8276⁃9.
［24］	Brenninkmeijer EE, Spuls PI, Legierse CM, et al. Clinical differences between atopic and atopiform dermatitis［J］. J Am Acad Dermatol, 2008,58（3）:407⁃414. doi: 10.1016/j.jaad.2007. 12.002.
［25］	Bos JD, Brenninkmeijer EE, Schram ME, et al. Atopic eczema or atopiform dermatitis［J］. Exp Dermatol, 2010,19（4）:325⁃331. doi: 10.1111/j.1600⁃0625.2009.01024.x.
［26］	Mori T, Ishida K, Mukumoto S, et al. Comparison of skin barrier function and sensory nerve electric current perception threshold between IgE⁃high extrinsic and IgE⁃normal intrinsic types of atopic dermatitis［J］. Br J Dermatol, 2010,162（1）:83⁃90. doi: 10.1111/j.1365⁃2133.2009.09440.x.
［27］	Vakharia PP, Chopra R, Silverberg JI. Systematic review of diagnostic criteria used in atopic dermatitis randomized controlled trials［J］. Am J Clin Dermatol, 2018,19（1）:15⁃22. doi: 10.1007/s40257⁃017⁃0299⁃4.
［28］	Saeki H, Furue M, Furukawa F, et al. Guidelines for management of atopic dermatitis［J］. J Dermatol, 2009,36（10）:563⁃577. doi: 10.1111/j.1346⁃8138.2009.00706.x.
［29］	Kang KF, Tian RM. Criteria for atopic dermatitis in a Chinese population［J］. Acta Derm Venereol Suppl （Stockh）, 1989,144:26⁃27.
［30］	张建中. 特应性皮炎的诊断标准发展及评价［J］. 中华皮肤科杂志, 2017,50（1）:67⁃69. doi: 10.3760/cma.j.issn.0412⁃4030. 2017.01.025.
［31］	Barrett M, Luu M. Differential diagnosis of atopic dermatitis［J］. Immunol Allergy Clin North Am, 2017,37（1）:11⁃34. doi: 10. 1016/j.iac.2016.08.009.
［32］	Guo Y, Zhang H, Liu Q, et al. Phenotypic analysis of atopic dermatitis in children aged 1⁃12 months: elaboration of novel diagnostic criteria for infants in China and estimation of prevalence［J］. J Eur Acad Dermatol Venereol, 2019,33（8）:1569⁃1576. doi: 10.1111/jdv.15618.

[1]	田静邓思思宋志强. 特应性与非特应性结节性痒疹患者临床特征比较[J]. 中华皮肤科杂志, 2024, 57(4): 331-337.
[2]	赵迎高翠娥隋昕宋志强. 基于高加索人单细胞转录组的炎症性树突状表皮细胞的免疫代谢研究[J]. 中华皮肤科杂志, 2024, 57(4): 343-349.
[3]	陈星宇姚煦. 中性粒细胞在炎症性皮肤病中的研究进展[J]. 中华皮肤科杂志, 2024, 0(3): 20220865-e20220865.
[4]	宗杨永怡马楚君苏忠兰. 银屑病生物制剂治疗后湿疹化发生机制及应对策略[J]. 中华皮肤科杂志, 2024, 0(3): 20220578-e20220578.
[5]	王煜坤刘洁. 深度学习在非肿瘤性皮肤病中的应用进展[J]. 中华皮肤科杂志, 2024, 0(3): 20220660-e20220660.
[6]	杨玉婷顾国林吴敏娟盛志杰李晋莫星帆吴敏智胥萍. 血清纤维连接蛋白联合梅毒非特异性抗体检测在梅毒血清固定患者中排除无症状神经梅毒的初步探讨[J]. 中华皮肤科杂志, 2024, 57(3): 246-249.
[7]	中国医学科学院皮肤病医院中国疾病预防控制中心性病控制中心中华医学会皮肤性病学分会性病学组中国康复医学会皮肤病康复专业委员会. [开放获取] 中国生殖支原体感染诊疗专家共识（2024）[J]. 中华皮肤科杂志, 2024, 57(3): 201-208.
[8]	谢琳陈锐牛建军杨天赐. 新型神经梅毒诊断标志物UCH-L1、GFAP和NF-L与传统神经梅毒检测指标的诊断效能比较[J]. 中华皮肤科杂志, 2024, 57(3): 224-232.
[9]	陈娜娜李峥张杰李世慎李伟. 南宁市147例隐性梅毒患者中早期感染情况的横断面调查[J]. 中华皮肤科杂志, 2024, 57(3): 213-217.
[10]	中华医学会皮肤性病学分会中国疾病预防控制中心性病控制中心中国医师协会皮肤科医师分会中国康复医学会皮肤病康复专业委员会. 中国沙眼衣原体泌尿生殖道感染临床诊疗指南（2024）[J]. 中华皮肤科杂志, 2024, 57(3): 193-200.
[11]	严可心张韡宋昊徐秀莲. 纳米医学在恶性黑色素瘤中的诊断和治疗新策略[J]. 中华皮肤科杂志, 2024, 0(3): 20230109-e20230109.
[12]	陈竹董丽萍肖风丽. 基于代谢组学探究特应性疾病的研究进展[J]. 中华皮肤科杂志, 2024, 0(3): 20220366-e20220366.
[13]	陈立新王莹高西波秦蓓李钦峰. 儿童经典型和色素减退型扁平疣反射式共聚焦显微镜特征及与组织病理的对应关系初探[J]. 中华皮肤科杂志, 2024, 57(3): 249-253.
[14]	中国医师协会皮肤科医师分会中华医学会皮肤性病学分会中国医疗保健国际交流促进会皮肤医学分会疑难重症及罕见病国家重点实验室国家皮肤与免疫疾病临床医学研究中心. 特应性皮炎治疗药物应用管理专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(2): 97-108.
[15]	中国“一带一路”皮肤病专病联盟分枝杆菌病研究联盟中国麻风防治协会皮肤性病检验与诊断分会. 中国皮肤非结核分枝杆菌病诊治专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(2): 109-118.

特应性皮炎的诊断：争议和事实

Diagnosis of atopic dermatitis: controversies and facts

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 32

相关文章 15

Metrics

本文评价

推荐阅读 10